Ryan D. Maynard

2016

In 2016, Ryan D. Maynard earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$147,740
Option Awards$493,380
Salary$454,585
Other$1,170
Total$1,096,875

Maynard received $493.4K in option awards, accounting for 45% of the total pay in 2016.

Maynard also received $147.7K in non-equity incentive plan, $454.6K in salary and $1.2K in other compensation.

Rankings

In 2016, Ryan D. Maynard's compensation ranked 7,792nd out of 14,075 executives tracked by ExecPay. In other words, Maynard earned more than 44.6% of executives.

ClassificationRankingPercentile
All
7,792
out of 14,075
45th
Division
Manufacturing
2,964
out of 5,489
46th
Major group
Chemicals And Allied Products
983
out of 1,895
48th
Industry group
Drugs
762
out of 1,538
51st
Industry
Pharmaceutical Preparations
607
out of 1,176
48th
Source: SEC filing on March 29, 2017.

Maynard's colleagues

We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2016.

2016

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2016

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2016

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2016

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

You may also like